SMTL ID : 7raj.1

Structure of PfCSP peptide 21 with antibody iGL-CIS43.D3

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.00 Å

Oligo State

hetero-1-1-1-mer

Ligands

1 x MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID(Non-covalent)

MES.1: 6 residues within 4Å: Chain A: G.42, Q.43, R.44 Chain B: D.9, G.106, G.107 2 PLIP interactions: 1 interactions with chain B, 1 interactions with chain A Salt bridges: B:D.9, A:R.44

2 x ZN: ZINC ION(Non-covalent)

ZN.2: 5 residues within 4Å: Chain A: G.170, H.172, T.191 Chain B: N.143, N.144 1 PLIP interactions: 1 interactions with chain A Metal complexes: A:H.172 ZN.3: 3 residues within 4Å: Chain B: D.157, K.194, H.195 2 PLIP interactions: 2 interactions with chain B Metal complexes: B:D.157, B:H.195

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kratochvil, S. et al., Vaccination in a humanized mouse model elicits highly protective PfCSP-targeting anti-malarial antibodies. Immunity (2021)

Release Date

2021-12-15

Peptides

iGL-CIS43.D3 Fab Heavy chain: A
iGL-CIS43.D3 Fab light chain: B
ASN-PRO-ASP-PRO-ASN-ALA-ASN-PRO-ASN-VAL-ASP-PRO-ASN-ALA-ASN: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
H

B
L

C
A

iGL-CIS43.D3 Fab Heavy chain

iGL-CIS43.D3 Fab light chain

ASN-PRO-ASP-PRO-ASN-ALA-ASN-PRO-ASN-VAL-ASP-PRO-ASN-ALA-ASN

Related Entries With Identical Sequence